Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis (Q33377727)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis (English)

1 reference

Europe PubMed Central

26 July 2017

glomerulonephritis

1 reference

based on heuristic

inferred from title

membranoproliferative glomerulonephritis

1 reference

based on heuristic

inferred from title

Giuseppe Remuzzi

object named as

G Remuzzi

2

0 references

author name string

M Noris

1

1 reference

Europe PubMed Central

26 July 2017

publication date

7 December 2007

1 reference

Europe PubMed Central

26 July 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

26 July 2017

151

1 reference

Europe PubMed Central

26 July 2017

2

1 reference

Europe PubMed Central

26 July 2017

199-209

1 reference

Europe PubMed Central

26 July 2017

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2007.03558.X

21 January 2018

Therapeutic plasma exchange: an update from the Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2007.03558.X

21 January 2018

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2007.03558.X

21 January 2018

Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2007.03558.X

21 January 2018

Membranoproliferative Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2007.03558.X

21 January 2018

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

New approaches to the treatment of dense deposit disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

A descriptive study of individuals with membranoproliferative glomerulonephritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Dense deposit disease: new insights

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Angiotensin blockade in children with chronic glomerulonephritis and heavy proteinuria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complement and diseases: defective alternative pathway control results in kidney and eye diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complement factor H polymorphism in age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complement factor H polymorphism and age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complement factor H variant increases the risk of age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Hemolytic Uremic Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Atypical relapse of hemolytic uremic syndrome after transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Challenges in the management of infantile factor H associated hemolytic uremic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Non-enteropathic hemolytic uremic syndrome: causes and short-term course.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Familial haemolytic uraemic syndrome and an MCP mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease")

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Management of membranoproliferative glomerulonephritis type II with plasmapheresis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Cyclosporin A treatment for membranoproliferative glomerulonephritis type II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Combined kidney and liver transplantation for familial haemolytic uraemic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Familial hemolytic uremic syndrome associated with complement factor H deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Management of membranoproliferative glomerulonephritis: evidence-based recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

The Nephrotic Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Recurrence of haemolytic-uraemic syndrome in renal transplants: a single-centre report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Complement-mediated adipocyte lysis by nephritic factor sera

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Regression of recurrent membranoproliferative glomerulonephritis type II in a transplanted kidney after plasmapheresis therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Dense deposit disease: a variant of membranoproliferative glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Further evidence for the antibody nature of C3 nephritic factor (C3NeF)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276938

31 October 2018

Childhood membranoproliferative glomerulonephritis: an approach to management

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

H deficiency in two brothers with atypical dense intramembranous deposit disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): Observations in Six Children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil treatment for therapy-resistant glomerulopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: successful treatment with plasmapheresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A C3 convertase assay for nephritic factor functional activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of factor H-related haemolytic uraemic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab for idiopathic membranous nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term corticosteroid and dipyridamole treatment of membranoproliferative glomerulonephritis type I in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmapheresis maintained renal function in an allograft with recurrent membranoproliferative glomerulonephritis type I

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term therapy with enalapril in patients with nephrotic-range proteinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ complement activation in porcine membranoproliferative glomerulonephritis type II

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escherichia coli O157:H7

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-center experience with cyclosporine in refractory nephrotic syndrome in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18070148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2007.03558.X

1 reference

Europe PubMed Central

26 July 2017

0 references

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33377727&oldid=1536538406"